ITOS
Price
$9.96
Change
-$0.06 (-0.60%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
381.21M
40 days until earnings call
SPRO
Price
$2.94
Change
+$0.04 (+1.38%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
164.66M
40 days until earnings call
Interact to see
Advertisement

ITOS vs SPRO

Header iconITOS vs SPRO Comparison
Open Charts ITOS vs SPROBanner chart's image
iTeos Therapeutics
Price$9.96
Change-$0.06 (-0.60%)
Volume$34.91K
Capitalization381.21M
Spero Therapeutics
Price$2.94
Change+$0.04 (+1.38%)
Volume$17.1K
Capitalization164.66M
ITOS vs SPRO Comparison Chart in %
Loading...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITOS vs. SPRO commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a Buy and SPRO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ITOS: $9.96 vs. SPRO: $2.94)
Brand notoriety: ITOS and SPRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 76% vs. SPRO: 30%
Market capitalization -- ITOS: $381.21M vs. SPRO: $164.66M
ITOS [@Biotechnology] is valued at $381.21M. SPRO’s [@Biotechnology] market capitalization is $164.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileSPRO’s FA Score has 1 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • SPRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRO is a better buy in the long-term than ITOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 5 TA indicator(s) are bullish while SPRO’s TA Score has 5 bullish TA indicator(s).

  • ITOS’s TA Score: 5 bullish, 4 bearish.
  • SPRO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ITOS is a better buy in the short-term than SPRO.

Price Growth

ITOS (@Biotechnology) experienced а -0.40% price change this week, while SPRO (@Biotechnology) price change was -2.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ITOS is expected to report earnings on Aug 07, 2025.

SPRO is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITOS($381M) has a higher market cap than SPRO($165M). SPRO YTD gains are higher at: 185.922 vs. ITOS (29.688). SPRO has higher annual earnings (EBITDA): -73.06M vs. ITOS (-146.71M). ITOS has more cash in the bank: 520M vs. SPRO (48.9M). SPRO has less debt than ITOS: SPRO (3.96M) vs ITOS (5.05M). ITOS has higher revenues than SPRO: ITOS (35M) vs SPRO (28.3M).
ITOSSPROITOS / SPRO
Capitalization381M165M231%
EBITDA-146.71M-73.06M201%
Gain YTD29.688185.92216%
P/E RatioN/A10.75-
Revenue35M28.3M124%
Total Cash520M48.9M1,063%
Total Debt5.05M3.96M128%
FUNDAMENTALS RATINGS
SPRO: Fundamental Ratings
SPRO
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSSPRO
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 24 days ago
73%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVAEX23.780.09
+0.38%
Macquarie Asset Strategy Fund Cl I
FKEMX42.88N/A
N/A
Fidelity Emerging Markets K
TEMUX15.46N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
KSMIX9.24N/A
N/A
Keeley Gabelli SMID Cap Value I
CFAGX46.26N/A
N/A
Commerce MidCap Growth

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-0.60%
BMRN - ITOS
50%
Loosely correlated
+2.01%
IMNM - ITOS
45%
Loosely correlated
-0.11%
BDTX - ITOS
44%
Loosely correlated
-4.07%
IBO - ITOS
44%
Loosely correlated
-18.26%
RCUS - ITOS
42%
Loosely correlated
-6.47%
More

SPRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with ASBP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then ASBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
+1.55%
ASBP - SPRO
58%
Loosely correlated
-3.63%
CLGN - SPRO
42%
Loosely correlated
+0.36%
ITOS - SPRO
35%
Loosely correlated
-0.60%
XENE - SPRO
32%
Poorly correlated
+0.65%
MGTX - SPRO
30%
Poorly correlated
-0.45%
More